Anti-tumor agent containing immunomodulator, and antitumor effect potentiator Grant US-11612653-B2 United States of America 28 Mar 2023
Method for treating cancer patients with severe renal impairment Grant US-10960004-B2 United States of America 30 Mar 2021
Stable crystal form of tipiracil hydrochloride and crystallization method for the same Application US-10457666-B2 United States of America 29 Oct 2019
Method for treating cancer patients with severe renal impairment Application US-10456399-B2 United States of America 29 Oct 2019
Stable crystal form of tipiracil hydrochloride and crystallization method for the same Application US-10138223-B2 United States of America 27 Nov 2018
Anti-tumor agent containing anti-tumor platinum complex, and anti-tumor effect enhancer Grant US-10092589-B2 United States of America 09 Oct 2018
Antitumor agent and antitumor effect enhancer Grant US-9943537-B2 United States of America 17 Apr 2018
Antitumor agent including low-dose irinotecan hydrochloride hydrate Grant US-9616081-B2 United States of America 11 Apr 2017
Antitumor agent including irinotecan hydrochloride hydrate Grant US-9616082-B2 United States of America 11 Apr 2017
Stable crystal form of tipiracil hydrochloride and crystallization method for the same Grant US-9527833-B2 United States of America 27 Dec 2016